Clinical Trials: Audit Trail Reviews in EDC

Components of an EDC Audit Trail

Posted on digi By digi

Electronic Data Capture (EDC) systems are used extensively in clinical trials to manage subject-level data entered into electronic case report forms (eCRFs). Every modification made to this data must be captured in a secure and traceable audit trail. This is not just a technical requirement — it is a regulatory obligation under ICH GCP, FDA 21 CFR Part 11, and EMA Annex 11. A well-structured audit trail helps ensure data integrity, compliance with ALCOA+ principles, and transparency during regulatory inspections.
Click to read the full article.

Audit Trail Reviews in EDC, Audit Trails and Inspection Readiness

How to Conduct an Audit Trail Review in EDC Systems

Posted on digi By digi

Audit trails in Electronic Data Capture (EDC) systems are essential for documenting the who, what, when, and why behind all data entries and changes made to electronic case report forms (eCRFs). Regulatory agencies including the FDA, EMA, and MHRA expect sponsors and CROs to regularly review these logs as part of their quality oversight obligations. Ignoring or inadequately reviewing audit trails can lead to critical GCP inspection findings, data integrity concerns, and even trial delays.
Click to read the full article.

Audit Trail Reviews in EDC, Audit Trails and Inspection Readiness

FDA Expectations for EDC Audit Trails

Posted on digi By digi

In the realm of FDA-regulated clinical research, Electronic Data Capture (EDC) systems must adhere to strict expectations for audit trail functionality. The U.S. Food and Drug Administration (FDA) uses audit trails to assess data integrity, monitor investigator oversight, and confirm compliance with regulations such as 21 CFR Part 11 and ICH E6(R2). These trails must provide a transparent, unalterable log of who did what, when, where, and why across the clinical data lifecycle.
Click to read the full article.

Audit Trail Reviews in EDC, Audit Trails and Inspection Readiness

Common Issues Identified in EDC Audit Logs

Posted on digi By digi

Electronic Data Capture (EDC) systems have revolutionized clinical trial data management, offering real-time access, automation, and traceability. However, with this digital advancement comes the critical responsibility of maintaining complete and accurate audit trails. Regulatory authorities like the FDA and EMA examine EDC audit logs to ensure the integrity of clinical data and compliance with GCP and 21 CFR Part 11 requirements.
Click to read the full article.

Audit Trail Reviews in EDC, Audit Trails and Inspection Readiness

Using Audit Trails to Investigate Data Discrepancies

Posted on digi By digi

Clinical data discrepancies — whether resulting from transcription errors, misreporting, or unauthorized modifications — pose serious risks to data integrity. Regulatory authorities such as the FDA and EMA expect sponsors and CROs to demonstrate how discrepancies are identified, investigated, and resolved. One of the most powerful tools for this purpose is the audit trail built into Electronic Data Capture (EDC) systems.
Click to read the full article.

Audit Trail Reviews in EDC, Audit Trails and Inspection Readiness

Configuring EDC Systems for ALCOA+ Compliance

Posted on digi By digi

The ALCOA+ framework—Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, and Available—defines the cornerstone of data integrity in clinical trials. For EDC (Electronic Data Capture) systems, achieving ALCOA+ compliance means more than maintaining data; it requires systematic tracking of changes, user activity, and reasons for data modifications.
Click to read the full article.

Audit Trail Reviews in EDC, Audit Trails and Inspection Readiness

Real-Time Monitoring of EDC Audit Trails

Posted on digi By digi

Electronic Data Capture (EDC) systems are the backbone of modern clinical data management, and with increasing regulatory scrutiny, real-time monitoring of EDC audit trails is becoming essential. Regulators expect sponsors and CROs to proactively detect issues—before an inspection occurs. Relying solely on periodic reviews is no longer sufficient to meet evolving data integrity standards under ALCOA+ and 21 CFR Part 11.
Click to read the full article.

Audit Trail Reviews in EDC, Audit Trails and Inspection Readiness

Training Sites on Reviewing EDC Audit Data

Posted on digi By digi

Electronic Data Capture (EDC) systems generate extensive audit trails that log every action—whether it’s a data entry, a correction, or an edit made to a patient record. Regulatory authorities such as the FDA, EMA, and MHRA expect these audit logs to be actively reviewed and understood not only by data managers and sponsors but also by the clinical site personnel responsible for entering and verifying data.
Click to read the full article.

Audit Trail Reviews in EDC, Audit Trails and Inspection Readiness

Automated vs Manual Audit Trail Evaluation

Posted on digi By digi

Electronic Data Capture (EDC) systems are central to modern clinical trials, and audit trails are their regulatory backbone. These audit logs meticulously record every action taken within the system, offering visibility into data entry, edits, deletions, and the reasons behind them. Regulatory bodies like the FDA, EMA, and MHRA require these trails to be reviewed and verified to ensure GCP compliance, traceability, and data integrity.
Click to read the full article.

Audit Trail Reviews in EDC, Audit Trails and Inspection Readiness

Handling Data Corrections in EDC Systems

Posted on digi By digi

Data corrections are a normal part of clinical trial operations. Investigators may need to revise information previously entered into an Electronic Data Capture (EDC) system due to typographical errors, source data updates, or protocol deviations. However, how these corrections are handled can have significant implications for regulatory compliance and inspection readiness.
Click to read the full article.

Audit Trail Reviews in EDC, Audit Trails and Inspection Readiness